Dr Reddy’s launches Avastin biosimilar in India 20-Aug-2019 By Vassia Barba Dr Reddy’s Laboratories enters a $31m market with the launch of Versavo, a biosimilar of Roche’s Avastin in India, indicated for several types of cancer.